News & Updates

Living alone appears to be associated with an increased risk of suicide, particularly among people with depression or anxiety, according to a population-based cohort study from Korea.

The selective serotonin reuptake inhibitor fluoxetine appears to modify lipid profile in individuals with overweight or obesity, with triglyceride levels reduced and high-density lipoprotein cholesterol (HDL-C) levels increased, according to a systematic review and meta-analysis.

Phenobarbital (PHB) may be used if patients remain in uncontrolled alcohol withdrawal syndrome (AWS) following treatment with benzodiazepines (BZD), suggests a study.

Mothers who conceived after medically assisted reproduction interventions appear to be less likely to have postpartum depression compared with those who conceived spontaneously, as suggested in a study.

For every four young people in Singapore, one has a history of nonsuicidal self-injury (NSSI), as shown in a study.

Treatment with the acetylcholinesterase inhibitor donepezil hydrochloride falls short of improving post–COVID-19 conditions such as fatigue and psychological symptoms, as shown in a study from Japan.

Repeated administration of low-dose lysergic acid diethylamide (LSD) in an outpatient setting is not necessarily better than placebo at reducing symptoms of attention-deficit/hyperactivity disorder (ADHD), according to the results of a phase IIA trial.

Individuals with rheumatoid arthritis (RA) are at an increased risk of developing anxiety or both depression and anxiety, according to a study.